Journal of Hazardous Materials
PFPeA exposure drives hepatoxicity and liver fibrosis via oxidative stress/Wnt5a-induced hepatocyte senescence
Experiments in miceCellular senescence
Papers on liver fibrosis
464 papers29 new in 30 days
Wednesday, January 14
Thursday, December 25
Journal of Controlled Release
Hepatocyte-specific partial cellular reprogramming via selective OSK mRNA lipid nanoparticle attenuates liver fibrosis
Experiments in miceLiver fibrosis
Thursday, December 18
Current Atherosclerosis Reports
Semaglutide and Tirzepatide for the Treatment of Obesity and Weight-Related Comorbidities: A Narrative Review
ReviewTirzepatide
Wednesday, December 10
Gastroenterology
Clusterin Drives Fiber Endocytosis by Mesothelial Cells to Resolve Liver Fibrosis
Experiments in miceLiver fibrosis
Tuesday, December 9
Diabetes, Obesity & Metabolism
Meta-analysis of clinically available pharmacotherapy of biopsy confirmed metabolic dysfunction associated steatohepatitis (MASH)
Meta-analysis of randomized trialsMetabolic dysfunction-associated steatohepatitis
Saturday, December 6
Annals of Hepatology
Genetic risk factors for MASLD/MASH and cardiovascular disease in elderly individuals
Cohort study of 5,244 peopleMechanisms
Wednesday, November 26
Cell Biology and Toxicology
NAD + in fatty liver disease: mechanistic insights and associated targets
ReviewMechanisms
Monday, November 24
Thursday, November 20
Wednesday, November 19
Thursday, November 6
Wednesday, November 5
Geriatrics & Gerontology International
The Role of an Elevated Fibrosis-4 Index in Neurocognitive Decline and Brain Volume Reduction in Older Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease
Cross-sectional study of 384 peopleMetabolic dysfunction-associated steatotic liver disease
Thursday, October 23
ENDO 2025 Abstract
SUN-591 GLP1-RA, SGLT2i and Risk of Advanced Fibrosis in Patients with T2D:a Target Trial Emulation
Cohort study of 67,722 peopleSGLT2 inhibitors
ENDO 2025 Abstract
SAT-536 How Do Metabolic Dysfunction Associated Steatosis Liver Disease (MASLD) and Depression in Veterans with T2DM respond to novel medications
Cross-sectional study of 58 peopleMetabolic dysfunction-associated steatotic liver disease
ENDO 2025 Abstract
SAT-662 GLP-1 And Advanced NASH: Impact On Liver Fibrosis Regression
Systematic review of studies in peopleLiver fibrosis
Tuesday, October 21
Clinical and Experimental Medicine
Sarcopenic visceral obesity in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
Cross-sectional study of 334 peopleVisceral obesity
Monday, October 20
Przeglad Menopauzalny
Burden of steatotic liver disease in postmenopausal women: NHANES 2017-2020 insights
Cross-sectional study in peopleSteatotic liver disease
Wednesday, October 15
Colloids and Surfaces B, Biointerfaces
Fe-Mn-IGF-AMD nanoparticles in accurate detection and treatment of liver cirrhosis via regulating relaxation coefficients and attenuating hepatocyte senescence
Experiments in animalsCirrhosis
Monday, October 13
medRxiv
Unveiling the Burden of MASLD and Liver Fibrosis in India: Novel Insights from the Phenome India Study into fibrosis without MASLD
Preprint: cohort study of 7,764 peopleLiver fibrosis
Sunday, October 12
Monday, October 6
Drug Design, Development and Therapy
Deciphering the Role of Oroxylin A in Liver Fibrosis
ReviewLiver fibrosis
Thursday, October 2
Phytomedicine
Spermidine enhances macrophages anti-inflammatory and regenerative functions by improving mitochondrial fitness
Experiments in miceSpermidine
Wednesday, October 1
Monday, September 22
Sunday, September 21
bioRxiv
Modeling Fibrosis with MASH Patient Liver-Derived Organoids
Preprint: experiments in human cellsMechanisms
Monday, September 15
International Journal of Biological Macromolecules
Roles and potential mechanisms of hepatic stellate cells activation mediated by epigenetics through insulin like growth factor 1 and receptor: A review
ReviewMechanisms
Tuesday, September 9
Lipids in Health and Disease
Body muscle mass versus fat mass: gender-specific associations with NAFLD and liver fibrosis
Cross-sectional study of 594 peopleLiver fibrosis
Thursday, August 28
Zhonghua Gan Zang Bing Za Zhi
Study on the correlation between sarcopenia, energy metabolism, and the severity of liver disease in patients with type 2 diabetes mellitus combined with metabolic associated fatty liver disease
Cross-sectional study of 94 peopleMuscle
Wednesday, August 27
Saturday, August 16
Genome Medicine
Aging increases susceptibility to liver fibrosis through enhanced NAT10-mediated ac4C modification of TGFβ1 mRNA
Experiments in miceMechanisms